Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jul;17(4):683-91.
doi: 10.1097/gme.0b013e3181d683b5.

Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative

JoAnn E Manson  1 , Matthew A Allison, J Jeffrey Carr, Robert D Langer, Barbara B Cochrane, Susan L Hendrix, Judith Hsia, Julie R Hunt, Cora E Lewis, Karen L Margolis, Jennifer G Robinson, Rebecca J Rodabough, Asha M Thomas; Women's Health Initiative and Women's Health Initiative-Coronary Artery Calcium Study Investigators
Collaborators, Affiliations
Randomized Controlled Trial

Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative

JoAnn E Manson et al. Menopause. 2010 Jul.

Abstract

Objective: Coronary artery calcified plaque is a marker for atheromatous plaque burden and predicts future risk of cardiovascular events. The relationship between calcium plus vitamin D (calcium/D) supplementation and coronary artery calcium (CAC) has not been previously assessed in a randomized trial setting. We compared CAC scores after trial completion between women randomized to calcium/vitamin D supplementation and women randomized to placebo.

Methods: In an ancillary substudy of women randomized to calcium carbonate (1,000 mg of elemental calcium daily) plus vitamin D3 (400 IU daily) or placebo, nested within the Women's Health Initiative trial of estrogen among women who underwent hysterectomy, we measured CAC with cardiac CT in 754 women aged 50 to 59 years at randomization. Imaging for CAC was performed at 28 of 40 centers after a mean of 7 years of treatment, and scans were read centrally. CAC scores were measured by a central reading center with masking to randomization assignments.

Results: Posttrial CAC measurements were similar in women randomized to calcium/D supplementation and those receiving placebo. The mean CAC score was 91.6 for women receiving calcium/D and 100.5 for women receiving placebo (rank test P value = 0.74). After adjustment for coronary risk factors, multivariate odds ratios for increasing CAC score cutpoints (CAC >0, > or =10, and > or =100) for calcium/D versus placebo were 0.92 (95% CI, 0.64-1.34), 1.29 (0.88-1.87), and 0.90 (0.56-1.44), respectively. Corresponding odds ratios among women with a 50% or higher adherence to study pills and for higher levels of CAC (>300) were similar.

Conclusions: Treatment with moderate doses of calcium plus vitamin D3 did not seem to alter coronary artery calcified plaque burden among postmenopausal women. Whether higher or lower doses would affect this outcome remains uncertain.

PubMed Disclaimer

Conflict of interest statement

No author reports any conflict of interest.

Figures

Figure 1
Figure 1
Odds ratios for coronary artery calcium (Agatson scores >0) according to calcium/vitamin D randomization status, stratified by baseline intake of calcium and vitamin D.
See this image and copyright information in PMC

Comment in

References

    1. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008;336(7638):262–266. - PMC - PubMed
    1. Hsia J, Heiss G, Ren H, et al. for the Women's Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846–854. - PubMed
    1. Grant AM, Avenell A, Campbell MK, et al. for the RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005;365:1621–1628. - PubMed
    1. Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure - results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006;166:869–875. - PubMed
    1. Cappuccio FP, Siani A, Strazzullo P. Oral calcium supplementation and blood pressure: an overview of randomized controlled trials. J Hypert. 1989;7:941–946. - PubMed

Publication types

MeSH terms